Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	2,807	2,859	2,816	3,106	2,218	1,790
Other Revenue	-	-	0.57	0.99	1.07	1.49
Revenue	2,807	2,859	2,816	3,107	2,219	1,792
Revenue Growth (YoY)	-7.95%	1.50%	-9.37%	40.06%	23.83%	30.28%
Cost of Revenue	2,638	2,667	2,703	2,779	1,899	1,642
Gross Profit	169.31	191.14	113.21	328.8	319.58	149.22
Selling, General & Admin	22.29	22.21	23.62	20.51	18.37	15.77
Other Operating Expenses	69.21	66.52	64.46	67.99	57.48	40.73
Operating Expenses	98.13	95.28	94.55	94.94	81.8	63.7
Operating Income	71.17	95.87	18.66	233.86	237.78	85.52
Interest Expense	-9.21	-6.74	-5.53	-9.3	-3.64	-9.37
Interest & Investment Income	-	-	3.05	2	1.38	0.86
Currency Exchange Gain (Loss)	-	-	0.32	1.53	0.6	-
Other Non Operating Income (Expenses)	10.79	9.73	-1.35	-3.02	-0.18	-3.4
EBT Excluding Unusual Items	72.75	98.86	15.15	225.07	235.94	73.6
Gain (Loss) on Sale of Investments	-	-	9.87	0.23	0.08	-
Gain (Loss) on Sale of Assets	-	-	0.18	-	-0.23	-
Other Unusual Items	-	-	-	-	-	-0.18
Pretax Income	72.75	98.86	25.2	225.3	236.01	73.44
Income Tax Expense	24.58	27.74	3.58	59	64.16	20.11
Net Income	48.18	71.12	21.63	166.31	171.85	53.33
Net Income to Common	48.18	71.12	21.63	166.31	171.85	53.33
Net Income Growth	33.21%	228.87%	-87.00%	-3.23%	222.22%	25.88%
Shares Outstanding (Basic)	3	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3	3
Shares Change (YoY)	0.01%	-0.00%	-	-	-	-
EPS (Basic)	15.59	23.02	7.00	53.83	55.62	17.26
EPS (Diluted)	15.59	23.02	7.00	53.83	55.62	17.26
EPS Growth	33.20%	228.89%	-87.00%	-3.23%	222.25%	25.89%
Free Cash Flow	-	-105.99	87.45	-108.96	161.98	20.69
Free Cash Flow Per Share	-	-34.30	28.30	-35.27	52.42	6.70
Dividend Per Share	-	1.000	1.000	1.000	1.000	-
Gross Margin	6.03%	6.69%	4.02%	10.58%	14.40%	8.33%
Operating Margin	2.54%	3.35%	0.66%	7.53%	10.72%	4.77%
Profit Margin	1.72%	2.49%	0.77%	5.35%	7.75%	2.98%
Free Cash Flow Margin	-	-3.71%	3.10%	-3.51%	7.30%	1.16%
EBITDA	77.74	102.42	25.12	240.28	243.71	90.44
EBITDA Margin	2.77%	3.58%	0.89%	7.73%	10.98%	5.05%
D&A For EBITDA	6.57	6.55	6.46	6.42	5.94	4.93
EBIT	71.17	95.87	18.66	233.86	237.78	85.52
EBIT Margin	2.54%	3.35%	0.66%	7.53%	10.72%	4.77%
Effective Tax Rate	33.78%	28.06%	14.19%	26.19%	27.19%	27.38%
Revenue as Reported	2,818	2,868	2,830	3,111	2,224	1,795
Advertising Expenses	-	-	1.43	1.72	0.62	0.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.